Coloplast A/S (OTCMKTS:CLPBY) Sees Unusually-High Trading Volume - Here's What Happened

Key Points

• Coloplast A/S saw unusually-high trading volume of about 1,164,778 shares on Friday (a 161% increase from the prior session); the ADR last traded at $6.62, down roughly 1.1%.
• In the latest quarter Coloplast reported EPS of $0.10, beating estimates of $0.09, while revenue was $1.11 billion versus estimates of $1.12 billion; analysts forecast 0.31 EPS for the current year.
• Sanford C. Bernstein upgraded the stock to a "hold" and the consensus rating is Hold; the company has a market cap of $14.85 billion, a PE ratio of 24.41 and a debt-to-equity of 1.50.

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY - Get Free Report) saw unusually-high trading volume on Friday . Approximately 1,164,778 shares changed hands during trading, an increase of 161% from the previous session's volume of 445,557 shares.The stock last traded at $6.62 and had previously closed at $6.6650.

Wall Street Analyst Weigh In

Separately, Sanford C. Bernstein upgraded Coloplast A/S to a "hold" rating in a research report on Wednesday, January 28th. Three analysts have rated the stock with a Hold rating, According to MarketBeat, Coloplast A/S presently has a consensus rating of "Hold".

Coloplast A/S Trading Down 1.1%

The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.81 and a current ratio of 1.30. The company has a market capitalization of $14.85 billion, a PE ratio of 24.41, a price-to-earnings-growth ratio of 0.69 and a beta of 0.33. The company has a 50 day simple moving average of $7.90 and a 200 day simple moving average of $8.65.

Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) last announced its quarterly earnings data on Friday, February 6th. The company reported $0.10 earnings per share for the quarter, beating analysts' consensus estimates of $0.09 by $0.01. The company had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.12 billion. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%. Analysts anticipate that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast's offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.